Too much death can kill you: inhibiting intrinsic apoptosis to treat disease
Journal Title
EMBO Journal
Publication Type
epub ahead of print
Apoptotic cell death is implicated in both physiological and pathological processes. Since many types of cancerous cells intrinsically evade apoptotic elimination, induction of apoptosis has become an attractive and often necessary cancer therapeutic approach. Conversely, some cells are extremely sensitive to apoptotic stimuli leading to neurodegenerative disease and immune pathologies. However, due to several challenges, pharmacological inhibition of apoptosis is still only a recently emerging strategy to combat pathological cell loss. Here, we describe several key steps in the intrinsic (mitochondrial) apoptosis pathway that represent potential targets for inhibitors in disease contexts. We also discuss the mechanisms of action, advantages and limitations of small-molecule and peptide-based inhibitors that have been developed to date. These inhibitors serve as important research tools to dissect apoptotic signalling and may foster new treatments to reduce unwanted cell loss.
Embo Press
Bak; Bax; Bcl-2; intrinsic apoptosis; mitochondria
WEHI Research Division(s)
Blood Cells And Blood Cancer; Ubiquitin Signalling
PubMed ID
Rights Notice
Refer to copyright notice on published article.

Creation Date: 2021-06-02 01:36:28
Last Modified: 2021-06-02 01:39:02
An error has occurred. This application may no longer respond until reloaded. Reload 🗙